Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Bulk Drug Intermediates >  (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester

(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester

Basic information Safety Supplier Related

(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester Basic information

Product Name:
(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester
Synonyms:
  • (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester
  • intermediate of abt594
  • (3R,4S)-benzyl 3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
  • Benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
  • Upadacitinib intermediate5
  • 1-Pyrrolidinecarboxylic acid, 3-(2-bromoacetyl)-4-ethyl-, phenylmethyl ester, (3R,4S)-
  • Upadacitinib intermediate
  • (3R,4S)-3-(2-Bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
CAS:
1428243-26-8
MF:
C16H20BrNO3
MW:
354.24
Mol File:
1428243-26-8.mol
More
Less

(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester Chemical Properties

Boiling point:
453.1±45.0 °C(Predicted)
Density 
1.361±0.06 g/cm3(Predicted)
pka
-2.91±0.60(Predicted)
InChI
InChI=1S/C16H20BrNO3/c1-2-13-9-18(10-14(13)15(19)8-17)16(20)21-11-12-6-4-3-5-7-12/h3-7,13-14H,2,8-11H2,1H3/t13-,14+/m1/s1
InChIKey
QEFUCTKHMXMWRF-KGLIPLIRSA-N
SMILES
N1(C(OCC2=CC=CC=C2)=O)C[C@@H](CC)[C@@H](C(CBr)=O)C1
More
Less

(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester Usage And Synthesis

Uses

(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester is a reagent in the preparation of imidazopyrrolopyrazine derivatives and analogs for use as protein kinase modulators.

Preparation

Dimethylsulfoxonium 2-((3R,4S)-1-benzyloxycarbonyl-4-ethylpyrrolidin-3-yl)-2-oxo-ethylide (10.0 g, 28.5 mmol, 1.0 equivalents), THF (100 mL), and 33% HBr in AcOH (8.37 g, 34.1 mmol, 1.2 equivalents) were charged sequentially and heated to 40° C. The reaction mixture was agitated for 5 hours, cooled to 20° C, and then distilled under vacuum to approximately 65 mL. EtOAc (20 mL) and heptane (50 mL) were charged, and the reaction mixture was washed with water (5×50 mL). The organic layer was concentrated under vacuum and chased with EtOAc (2×50 mL) concentrating to dryness each time. N,N-dimethylacetamide (20 mL) was then charged to provide 30.8 g of a 24.0 wt/wt % solution of (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester (yield: 73%). 

(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl esterSupplier

Shanghai Rochi Pharmaceutical Co., Ltd. Gold
Tel
021-38751876 15000076078
Email
Info@rochipharma.com
Heading (Nanjing)Pharmtechnologies Co., Ltd. Gold
Tel
025-58467899-832 13382406280
Email
liucheng@headingpharm.com
Foshan Junzheng Biotechnology Co., Ltd Gold
Tel
17813018085
Email
181367029@qq.com
Hangzhou Chemtrue Bio-Tech Co.,Ltd. Gold
Tel
0571-86828652 19967494293
Email
sales@chemtrue-bio.com
Cangzhou Kangrui Medical Technology Co., LTD Gold
Tel
18632776803
Email
355803330@qq.com